Brent Steven McKenzie

Title: Brent Steven McKenzie: Innovator in Immunology

Introduction

Brent Steven McKenzie is a notable inventor based in Upwey, Australia. He has made significant contributions to the field of immunology, particularly through his innovative approaches to vaccine development. With a total of 2 patents, McKenzie has focused on methods that enhance immune responses in animals.

Latest Patents

McKenzie’s latest patents include groundbreaking inventions aimed at improving vaccine efficacy. The first patent, titled "Relay Vaccine," provides a method and composition for raising an immune response in an animal. This method involves administering a composition that includes a carrier and an antigen bound to a targeting moiety. The targeting moiety is designed to bind to receptors that are upregulated on lymphocytes, which are crucial for homing to mucosal lymphoid tissues. The second patent, "Antigen Targeting," outlines a method for raising an immune response by administering a composition that also includes a carrier and an antigen bound to a targeting moiety. This targeting moiety is intended to bind to receptors present in circulatory vessels within Gut Associated Lymphoid Tissue, with a preference for binding to Mucosal Addressin Cellular Adhesion Molecule-1.

Career Highlights

Throughout his career, McKenzie has worked with esteemed organizations, including the Queensland Institute of Medical Research. His work has been pivotal in advancing the understanding of immune responses and developing innovative solutions in the field of immunology.

Collaborations

McKenzie has collaborated with notable colleagues such as Jefferey Stephen Boyle and Andrew Mark Lew. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Brent Steven McKenzie stands out as an influential inventor in the realm of immunology. His innovative patents and collaborations reflect his commitment to advancing medical science and improving vaccine technology.